Division of Nephrology and Clinical Research Institute, Department of Internal Medicine, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Department of Nephrology, Nara Medical University, Nara, Japan.
Hypertens Res. 2021 Nov;44(11):1492-1504. doi: 10.1038/s41440-021-00741-y. Epub 2021 Sep 3.
A higher urinary sodium-to-potassium (UNa/K) ratio has been reported to be associated with high blood pressure and subsequent cardiovascular events. However, the association between the UNa/K ratio and renal outcomes remains uncertain. We prospectively investigated the association between the UNa/K ratio and renal outcomes in patients with chronic kidney disease (CKD). We enrolled 716 patients with CKD, and 24-h urinary sodium and potassium excretion were measured. Patients were divided into UNa/K ratio tertiles (T1-T3). Endpoints were defined as a composite of doubling of serum creatinine (SCr), end-stage kidney disease (ESKD), or death and a composite of doubling of SCr or ESKD (added as an alternative outcome). We investigated the association between the UNa/K ratio and renal outcomes using a Cox proportional hazards model. During a median follow-up of 2.3 years, doubling of SCr, ESKD, or death and doubling of SCr or ESKD occurred in 332 and 293 patients, respectively. After adjustment for covariates including potentially confounding variables such as plasma renin activity, plasma aldosterone concentration, and B-type natriuretic peptide, the hazard ratios (HRs) (95% confidence intervals [CIs]) for the composite of doubling of SCr, ESKD, or death for T2 and T3 were 1.44 (1.06-1.96) and 1.59 (1.14-2.21), respectively, compared with T1. Additionally, compared with T1, the highest tertile (T3) of the UNa/K ratio was associated with a composite of doubling of SCr or ESKD (HR 1.55, 95% CI 1.09-2.20). A higher UNa/K ratio was independently associated with poor renal outcomes in patients with CKD.
尿钠/钾(UNa/K)比值升高与高血压和随后的心血管事件有关。然而,UNa/K 比值与肾脏结局之间的关系尚不确定。我们前瞻性研究了慢性肾脏病(CKD)患者中 UNa/K 比值与肾脏结局之间的关系。我们纳入了 716 例 CKD 患者,测量了 24 小时尿钠和钾排泄量。患者被分为 UNa/K 比值三分位组(T1-T3)。终点定义为血清肌酐(SCr)倍增、终末期肾病(ESKD)或死亡的复合终点,以及 SCr 倍增或 ESKD 的复合终点(另作为替代终点)。我们使用 Cox 比例风险模型研究了 UNa/K 比值与肾脏结局之间的关系。在中位随访 2.3 年期间,分别有 332 例和 293 例患者发生了 SCr 倍增、ESKD 或死亡以及 SCr 倍增或 ESKD。在校正了包括潜在混杂因素如血浆肾素活性、血浆醛固酮浓度和 B 型利钠肽等变量后,T2 和 T3 组的复合终点(SCr 倍增、ESKD 或死亡)的风险比(HR)(95%置信区间[CI])分别为 1.44(1.06-1.96)和 1.59(1.14-2.21),与 T1 相比。此外,与 T1 相比,UNa/K 比值最高的三分位组(T3)与 SCr 倍增或 ESKD 的复合终点相关(HR 1.55,95%CI 1.09-2.20)。较高的 UNa/K 比值与 CKD 患者的不良肾脏结局独立相关。